CRTC1-MAML2 (and, to lesser extent, CRTC3-MAML2) has been detected in the majority of human MEC cases, and MAML2 break-apart FISH currently serves as a biomarker for MEC diagnosis. This evidence concerns the gene CRTC1 and mucoepidermoid carcinoma.